Cargando…

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Detalles Bibliográficos
Autores principales: Benotmane, Ilies, Bruel, Timothée, Planas, Delphine, Fafi-Kremer, Samira, Schwartz, Olivier, Caillard, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881812/
https://www.ncbi.nlm.nih.gov/pubmed/35231463
http://dx.doi.org/10.1016/j.kint.2022.02.011
_version_ 1784659561020391424
author Benotmane, Ilies
Bruel, Timothée
Planas, Delphine
Fafi-Kremer, Samira
Schwartz, Olivier
Caillard, Sophie
author_facet Benotmane, Ilies
Bruel, Timothée
Planas, Delphine
Fafi-Kremer, Samira
Schwartz, Olivier
Caillard, Sophie
author_sort Benotmane, Ilies
collection PubMed
description
format Online
Article
Text
id pubmed-8881812
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88818122022-02-28 A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients Benotmane, Ilies Bruel, Timothée Planas, Delphine Fafi-Kremer, Samira Schwartz, Olivier Caillard, Sophie Kidney Int Research Letter International Society of Nephrology. Published by Elsevier Inc. 2022-05 2022-02-26 /pmc/articles/PMC8881812/ /pubmed/35231463 http://dx.doi.org/10.1016/j.kint.2022.02.011 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Benotmane, Ilies
Bruel, Timothée
Planas, Delphine
Fafi-Kremer, Samira
Schwartz, Olivier
Caillard, Sophie
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title_full A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title_fullStr A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title_full_unstemmed A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title_short A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
title_sort fourth dose of the mrna-1273 sars-cov-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881812/
https://www.ncbi.nlm.nih.gov/pubmed/35231463
http://dx.doi.org/10.1016/j.kint.2022.02.011
work_keys_str_mv AT benotmaneilies afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT brueltimothee afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT planasdelphine afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT fafikremersamira afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT schwartzolivier afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT caillardsophie afourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT benotmaneilies fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT brueltimothee fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT planasdelphine fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT fafikremersamira fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT schwartzolivier fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients
AT caillardsophie fourthdoseofthemrna1273sarscov2vaccineimprovesserumneutralizationagainstthedeltavariantinkidneytransplantrecipients